http://web.archive.org/web/20130224113529id_/http://www.dailymail.co.uk/news/article-2270441/Thousands-families-face-diabetes-drug-battle-GSK-vows-challenge-compensation-requests.html

by @entity0 published : 20:47 est , 29 january 2013 updated : 03:24 est , 30 january 2013 thousands of @entity2 families could be denied compensation for the deaths or illness of relatives caused by a dangerous diabetes drug , despite similar cases being settled at a cost of billions of dollars in the @entity10 pharmaceutical giant @entity13 has agreed to pay claims of victims in the @entity10 , but it has told @entity2 victims that it will challenge their requests for compensation in court , their lawyers have said			1
the diabetes drug @entity21 had its @entity23 licence revoked in september 2010 because of evidence it could cause heart failure or heart attacks			1
danger : the diabetes drug @entity21 had its @entity23 licence revoked in september 2011 because of evidence it could cause heart failure or heart attacks @entity13 , which is based in the @entity2 , has admitted concealing data about the damaging side effects of the drug , but it has told victims it is not willing to settle @entity2 claims without a court fight			1
@entity37 , of @entity39 solicitors , which is representing 19 victims , said that that unlike in the @entity10 where @entity13 has settled claims outside of court , it will contest the cases here			1
he said that it will now take years for bereaved families or those harmed by the drug to get any sort of compensation			0
he told @entity51 : ‘ it is very disappointing			0
we anticipate that these claims do have a good prospect of success , but they still have to prove their case in the @entity2 with suitable evidence			2
‘ they are tasked with having to produce that evidence , including medical expert opinion			0
it is a burden one would have thought they might not have to go through			0
’ a spokesman for @entity13 told the newspaper : ‘ we have every sympathy for people with complications associated with diabetes and those who care for them , but unfortunately we are unable to comment on individual legal cases			2
‘ we continue to believe that the company acted appropriately and responsibly in its management of @entity21			2
’ battle : @entity13 has told victims in @entity2 it is not willing to settle claims without a court fight there were around 90,000 people taking @entity21 in the @entity2 when it was banned , eight years after it was introduced in the @entity83 in 2000			1
it was given to people with type 2 diabetes whose glucose levels could not be controlled by standard drugs			0
trials on the drug found that it could cause heart attacks and made patients more likely to suffer strokes and heart failure			1
@entity13 pleaded guilty to federal charges of concealing data about the drug ’s side effects			0
it agreed to pay $ 3bn to the @entity10 government in november 2011 over issues with the drug and to end investigations into the marketing of antidepressants @entity105 and @entity106 .			0

drug company has settled similar cases in @entity10 at cost of billions of dollars
diabetes drug @entity21 had licence revoked over fears it could cause heart attacks or heart failure in september 2010
@entity13 not willing to settle @entity2 claims without a court fight

@entity2:British
@entity21:Avandia
@entity13:GlaxoSmithKline
@entity37:Daniel Slade
@entity23:European
@entity39:Express
@entity10:US
@entity51:The Guardian
@entity0:John Stevens
@entity105:Paxil
@entity106:Wellbutrin
@entity83:NHS